Pallas Health vs Sunlight: Clinician-selected plans or $88 starts
Quick verdict: Pallas Health centers clinician selection between FDA-approved brand pens and compounded GLP-1s with a first month of compounded semaglutide at $139 then $199 per month average, while Sunlight emphasizes a low entry price from $88 per month with a promise of the same price forever. This comparison focuses on pricing structure, medication options and regulatory notes, care model, and shipping and renewal terms to help you choose.
Start Pallas intake and see clinician options
Pricing structure compared
Pallas Health: compounded semaglutide is $139 for the first month then $597 every 12 weeks, a $199 per month average; compounded tirzepatide is $179 first month then $897 every 12 weeks, a $299 per month average. Brand-name medications are listed as cash-pay monthly prices with specific figures for Wegovy, Zepbound, Ozempic and Mounjaro. Pallas notes plan prices include provider care, check-ins and messaging and that pricing changes so users should confirm current figures before ordering.
View Pallas pricing and plan details
Sunlight: advertising personalized GLP-1 from $88 per month and a stated same price forever policy. Site captures a Summer Promo and language saying as low as $88 with free shipping, prescription and telehealth included. Sunlight also cautions that pricing, eligibility, pharmacy, state coverage and renewal terms may change.
See Sunlight plans starting at $88 per month
Pallas Health vs Sunlight on medication options and regulatory notes
Pallas Health offers both FDA-approved brand-name GLP-1s and clinician-personalized compounded semaglutide or tirzepatide prepared by US-licensed compounding pharmacies when a brand medication is not the right fit. Pallas explicitly states compounded medications are not FDA-approved and are not generic versions of brand-name drugs.
Sunlight markets injections and oral GLP-1 options with prescription and telehealth included. Sunlight includes a regulatory reminder that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. Neither provider claim converts regulatory statements into assurances beyond what the sites state.
Care model and telehealth differences
Pallas Health describes a US-licensed clinician reviewing health history and personalizing the plan, with provider care, ongoing check-ins and care-team messaging included in one all-in plan price and no membership fee. Pallas notes 100 percent online care and that in most states the program is asynchronous, but a video visit is required in seven states plus Washington, D.C. Care-team hours are weekdays 9 AM to 5 PM ET and emergency services are not offered.
Sunlight advertises a 100 percent online medical visit with prescription and telehealth included, no insurance required, and claims same price every month. Sunlight materials include patient testimonials about clinician adjustments and customer service responsiveness. Sunlight tells users to confirm eligibility, medication, total cost, renewal terms and state availability before enrollment.
Shipping, renewals and membership
Pallas Health states free expedited and discreet shipping on every plan, compounded in the USA, and that plans renew every 12 weeks for compounded medications which means cancellation timing matters. Pallas is cash-pay only and does not bill insurance. It notes FSA or HSA eligibility may require a Letter of Medical Necessity.
Sunlight states fast free shipping in 1 to 2 days and free discreet 2-day shipping in captured landing text, no monthly membership, cancel anytime, and an explicit claim of same price forever. Sunlight also includes promo language in captured landing content and advises confirmation of terms as they may change.
Direct comparison table
| Criteria | Pallas Health | Sunlight |
|---|---|---|
| Starting price | Compounded semaglutide $139 first month then $199/mo avg | From $88 per month advertised |
| Medication options | FDA-approved brands and clinician-personalized compounded GLP-1s | Injections and oral GLP-1 options, personalized plans |
| Regulatory note | Compounded meds are not FDA-approved | Approval status must be confirmed; branded and compounded not interchangeable |
| Care model | US-licensed clinician review, check-ins and messaging included; asynchronous in most states | 100 percent online medical visit with prescription and telehealth included |
| Shipping and renewal | Free expedited shipping; compounded plans renew every 12 weeks | Free 1 to 2 day shipping; claims same price every month |
Check Sunlight eligibility and shipping details
Pallas Health vs Sunlight: final take
Use the primary keyword Pallas Health vs Sunlight to remember the main tradeoffs: Pallas centers clinician choice between brand-name pens and compounded preparations with explicit compounded pricing and a plan price that includes provider care, while Sunlight emphasizes a low advertised entry price from $88 per month and a promise of same price forever with telehealth included. Both are 100 percent online but differ on compounded availability, pricing cadence and stated regulatory notes.
Choose Pallas Health if you want a clinician to choose between FDA-approved brand-name GLP-1s and a US-compounded preparation, if you prefer an all-in plan price that includes provider care and messaging, or if you value the explicit compounded pricing of $139 first month then $199 per month average for semaglutide.
Choose Sunlight if your priority is the lowest advertised starting price and a stated same price every month policy with injection and oral options and fast free shipping, noting that Sunlight advises confirming eligibility, state availability and renewal terms before enrolling.